We propose model-based inference for differential gene expression, using a non-parametric Bayesian probability model for the distribution of gene intensities under different conditions. The probability model is essentially a mixture of normals. The resulting inference is similar to the empirical Bayes approach proposed in Efron et al. (2001) . The use of fully modelbased inference mitigates some of the necessary limitations of the empirical Bayes method.
INTRODUCTION
We discuss the use of nonparametric Bayesian inference to analyze data from microarray experiments conducted to screen for differential gene expression over conditions of interest.
We define a model-based version of the empirical Bayes approach proposed in Efron et al. (2001) . The probability model is a variation of traditional Dirichlet process (DP) mixture models. The model includes an additional mixture corresponding to the assumption that observed transcription levels arise as a mixture over non-differentially and differentially expressed genes. Inference proceeds as in DP mixture models, with an additional set of latent indicators to resolve the additional mixture.
Background
With the recent advent in DNA array technologies, a new class of large data sets emerge from microarray experiments that allow researchers to measure the relative expression of thousands of genes simultaneously. Microarrays measure mRNA concentrations by labeling the sample with a dye and then allowing them to hybridize to spots on the array. Each spot contains either DNA oligomers (typically 25 nucleotides) or a longer DNA sequence (hundreds of nucleotides long) designed to be complementary to a particular messenger RNA of interest. There are two main types of arrays: Oligonucleotide arrays generated by photolithography techniques to synthesize oligomers directly on the glass slide (primarily Affymetrix arrays); and cDNA arrays generated by mechanical gridding, where prepared material is applied to each spot by ink-jet or physical deposition. For oligonucleotide microarrays, cross-hybridization may occur, that is, multiple genes may hybridize to the same spot. Therefore oligonucleotide arrays must measure each gene with a probe set of oligomers (for example, Affymetrix arrays use probe set sizes of 32-40), and the identification of a gene is only made if "positive" hybridization can be detected in the majority of the probes in the set. Oligonucleotide arrays are manufactured with probes that form a perfect match (PM) and a mismatch (MM) with the target polynucleotide of interest. The PM oligo probe will contain a segment of a wild-type allele (creating a perfect complementary match with a segment of the target polynucleotide of interest), while the MM oligo probe will be a copy of the PM oligo that has been altered by one base at a central position, usually the thirteenth position. In current practice, Affymetrix oligonucleotide arrays measure a single sample at a time with a single type of dye. In contrast, cDNA microarrays can use two or more different fluorescent dyes to label different samples, thus allowing simultaneous monitoring of multiple samples on the same array. See Wu (2001) for a gentle introductory review of microarray technologies. Statistical methods applicable to the analysis of such data have an important role to play in the discovery, validation, and understanding of various classes and subclasses of cancer. See, for example, Eisen et al. (1998) , Alizadeh et al. (2000) , Ben-Dor et al. (1999 , Alon et al. (1999) , Golub et al. (1999) , Moler et al. (2000) , and Xing and Karp (2001) , among other. The different stages of a microarray experiment (not necessarily distinct) include experimental design, image analysis, graphical presentation and normalization, identification of differentially expressed genes, and finally clustering or classification of the gene expression profiles. See Smyth et al. (2002) for a review of statistical issues and corresponding methods for these numerous stages. In this article, we use the term "expression level" to refer to a summary measure of relative red to green channel intensities in a fluorescence-labeled cDNA array or a summary difference of the PM and MM scores from an oligonucleotide array.
Inference for Differential Expression
Recently, statisticians and researchers in bioinformatics have focused much attention on the development of statistical methods to identify differentially expressed genes, with special emphasis on those methods that identify genes that are differentially expressed between two conditions. There are two main approaches to distinguish real signals from noise in a chip-to-chip comparison: thresholding or replicate analysis. The latter approach is desirable but expensive. The former approach involves imposing an arbitrary threshold of signal difference, or fold-change ratio, between experimental and control samples, above which differences are considered to be real. Often differential expression is assessed by taking ratios of expression levels of different samples at a spot on the array and flagging those where the magnitude of the fold difference exceeds some threshold, possibly allowing for the fact that the variability of these ratios is not constant across mean expression levels.
For example, an increase or decrease of at least twofold may be considered as significant.
The use of fold-change ratios can be inefficient and erroneous. The uncertainty associated with dividing two intensity values further increases overall errors (Newton et al., 2001; Yang et al., 2001; Miles, 2001) . The methods are often variants of Student's t-test that conduct a hypothesis test at each gene and subsequently correct for multiple comparisons. Earlier simple methods were discussed in Schena et al. (1995) , Schena et al. (1996) , DeRisi et al. (1996) and and Lönnstedt and Speed (2002) . Chen et al. (1997) considered a less arbitrary threshold by using replicated housekeeping genes; and more recently methods that implicitly assume non-constant coefficient of variation were discussed by Baggerly et al. (2001 ), Newton et al. (2001 , and Rocke and Durbin (2001) .
A recent strategy for the detection of differentially expressed genes, called significance analysis of microarrays (SAM), has been described by Tusher et al. (2002) . SAM identifies genes with statistically significant changes in expression by assimilating a set of gene-specific t-tests. The approach incorporates means and standard deviations across experimental conditions in the computation of a relative difference in gene expression. Each gene is assigned a score on the basis of its change in gene expression relative to the standard deviation of the repeated measurements for this specific gene corresponding to different experimental conditions. To prevent the denominator of the t-statistic from getting too small, Tusher et al. (2002) proposed a refinement of the t statistic by adding a constant term a 0 to the denominator of the standardized average. The constant term a 0 can be taken to equal the nth percentile of the standard errors of all the genes, as suggested by Efron et al. (2001) , or as a value that minimizes the coefficient of variation of the t-statistic, as suggested by Tusher et al. (2002) .
A number of researchers have employed mixture modeling approaches in the analysis of microarray data. For example, McLachlan et al. (2002) developed the software EMMIX-GENE that includes a mixture of t distributions, using the Student-t family as a heavy-tailed alternative to the normal distribution. The use of a mixture of normal distributions as a flexible and powerful tool to estimate the two distributions related to gene expression has been discussed, for example, in Pan et al. (2002) . They use a parametric bootstrap technique to choose a cut point in declaring statistical significance for identified genes while controlling for the number of false positives. Efron et al. (2001) discuss, in addition to other methods, the use of density estimates to approximate the distribution of transcription levels for differentially and non-differentially expressed genes. The main thrust of the discussion in Efron et al. (2001) is an empirical Bayes approach. They compute the posterior probability of differential expression by substituting estimates of relevant parameters and (ratios of) densities based on the empirical distribution of observed transcription levels. We propose an extension of the method discussed by Efron et al. (2001) . Analogous to Efron's empirical Bayes approach, our approach starts with assuming that the observed expression scores are generated from a mixture of two distributions that can be interpreted as distributions for affected and unaffected genes, respectively. The desired inference about differential expression for a particular gene amounts to solving a deconvolution problem corresponding to this mixture. While Efron et al. (2001) proceed by plugging in point estimates, we choose a fully model-based approach. We construct a probability model for the unknown mixture, allowing investigators to deduce the desired inference about differential expression as posterior inference in that probability model. We choose Dirichlet process mixture models to represent the probability model for the unknown distributions. We develop Markov chain Monte Carlo (MCMC) posterior simulation to generate samples from the relevant posterior and posterior predictive distributions. Alon et al. (1999) used Affymetrix oligonucleotide arrays to monitor expressions of over 6,500 human gene expressions in 40 tumor and 22 normal colon tissue samples. The samples were taken from 40 different patients, with 22 patients supplying both a tumor and normal tissue sample. Alon et al. (1999) focused on the 2,000 genes with highest minimal intensity across the samples, and it is these 2,000 genes that comprise our data set. The microarray data matrix thus has n = 2, 000 rows and p = 62 columns. We have rearranged the data so that From the data matrix we construct two difference matrices, D and d. The first matrix, D, contains all the possible differences between tumor and normal tissues within the same protocol (P1 or P2), with the i-th row of D defined as the vector of all differences for the i-th gene. The other matrix, d, contains all possible differences within the same conditions and same protocol, i.e., differences between all pairs of tumor columns, and between all pairs of normal columns collected under the same protocol. Also, in constructing D, we exclude differences of paired columns corresponding to the same patient. Including such differences would require the introduction of patient specific random effects to model the difference in variation between differences of paired and independent columns, respectively. Thus patient to patient variation as well as any other noise is included in both, d and D. But possible effects due to differential expression in tumor versus normal tissues are included only in D.
DATA
We refer to d as the null sample, reporting only measurement error, and D as the mixed sample, including noise plus a tumor versus normal effect for differentially expressed genes.
The goal of the upcoming discussion is to identify those genes that are differentially expressed across the two conditions and separate the mixed sample into a subset of non-differentially expressed genes for which D reports only noise as in d, and differentially expressed genes that show an additional effect in D.
Let D i and d i denote the average of all elements in D and d, respectively, corresponding to gene i, i.e., the average in the i-th row D i and d i , respectively. Similar to Efron et al. (2001) , we construct two sets of Z scores, Z null and Z mix , obtained as
where S i and s i are respectively the standard deviations of D i and d i . The offsets α 0 and α 0 are the correction scores. We use α 0 = α 0 = 0.
A MIXTURE MODEL FOR GENE EXPRESSION
We assume that a gene is either affected or unaffected by the condition of interest. Hence we can write the distribution of expression scores Z mix i as a mixture of two density functions, f 0 and f 1 , representing the density function under unaffected and affected conditions,
where p 0 is the proportion of genes that are not differentially expressed across the two experimental conditions. The main inference question of interest is about the probability of differential expression. Using Bayes' rule for given (f 0 , f 1 , p 0 ) we find from (1) the posterior probability of differential expression
and the complementary probability of non-differential expression
Both posterior probabilities are conditional on assumed (f 0 , f 1 , p 0 ). Efron et al. (2001) propose to estimate P 0 by an empirical Bayes approach, substituting point estimates for f 0 /f and p 0 . To estimate f 0 /f they construct a logistic regression experiment, set up such that the odds are π(Z) = f (Z)/(f (Z) + f 0 (Z)). The resulting estimate π gives an implied estimate q = (1 − π)/ π for q = f 0 /f . To derive a point estimate for p 0 they observe that non-negativity of P 1 implies p 0 ≤ min Z f (Z)/f 0 (Z), and propose to substitute the bound as point estimate p 0 ≡ min Z f (Z)/f 0 (Z). We will refer to the resulting estimates P 0 (Z) = p 0 q(Z) and P 1 (Z) = 1 − P 0 (Z) as empirical Bayes estimates. The bound p 0 overestimates p 0 and hence introduces a corresponding bias in P 0 (Z) and P 1 (Z).
This limitation of the empirical Bayes approach can be overcome by a fully model-based
Bayesian approach that introduces a probability model on (f 0 , f 1 , p 0 ) and computes posterior probabilities of differential expression as appropriate marginal posterior probabilities.
Non-parametric Bayesian Approach (NPBA)
Defining a prior probability model for the unknown quantities in (1), and combining this with the relevant sampling distributions we can derive a posterior distribution for the unknown f 0 , f 1 and p 0 . The implied posterior distribution on P 1 = (1 − p 0 )f 1 /f provides the desired probabilities of differential expression. The key advantages of this approach are that it replaces point estimates for f 0 /f and p 0 by a full description of uncertainties and appropriately accounts for these uncertainties. Also, the approach inherits other relevant advantages of coherent posterior inference. In particular, once we introduce a joint probability model across all genes and samples, we can provide joint inference on multiple genes, and we include accounting for multiplicities in the usual Bayesian fashion. We illustrate these two issues in the context of examples in section 5.
Defining a prior probability model for inference in (2) requires investigators to choose a probability model for the unknown densities f 0 and f 1 . Bayesian inference for random distributions, like f 0 and f 1 , is known as nonparametric Bayesian inference (Walker et al., 1999) . By far the most popular nonparametric Bayesian model is the Dirichlet process (DP).
A random probability distribution G is generated by a DP if for any partition A 1 , . . . , A k of the sample space the vector of random probabilities G(A i ) follows a Dirichlet distribution:
Two parameters need to be specified: a scalar parameter M , and the base measure G . The base measure G defines the expectation, E{G(B)} = G (B), and M is a precision parameter that defines variance. Properties and definition of the DP are discussed, among others, in Ferguson (1973) or Antoniak (1974) . A useful result is the construction by Sethurman (1994) . Let δ x denote a point mass at x. Any G ∼ DP(M, G ) can be represented as
∼ G , and
In words, realizations of the DP are almost surely discrete. The locations µ h of the point masses are a sample from G , and the random weights w h are generated by a "stick-breaking" procedure. The almost sure discreteness is inappropriate in many applications. A simple extension to remove the constraint to discrete measures is to introduce an additional convolution, representing a random probability measure F as
Such models are known as DP mixtures (MDP) (Escobar, 1988; MacEachern, 1994; Escobar and West, 1995) . Using a Gaussian kernel,
and mixing with respect to θ = (µ, S) we obtain density estimates resembling traditional kernel density estimation. See, for example, MacEachern and Müller (2000) for a recent review of MDP models and posterior simulation methods.
We use DP mixture models as in (4) to define prior models for f 0 and f 1 . Let N(x; m, S) denote a normal probability density function for the random variable x with moments (m, S).
We assume
Using the stick-breaking representation (3), we can write model (5) equivalently as
with locations µ h and weights ω h generated by the stick-breaking prior (3). An analogous representation holds for f 1 . Thus, similar to McLachlan et al. (2002) and Pan et al. (2002) , we represent the unknown densities f 0 and f 1 as mixtures of normals. For the base measures G j we use
The base measure for the null scores is unimodal, centered at zero. The base measure for scores from differentially expressed genes is symmetric bimodal, reflecting the prior belief that differential expression (on the log scale) in either direction is equally likely.
For notational convenience, we relabel the data as z i , i = 1, · · · , n, for the null sample
denote the sampling distribution for the mixed sample. For the null sample, the sampling distribution is f 0 itself, without the additional mixture in f . In summary, the likelihood is
We complete the model with a prior probability model for p 0 and the parameters of the base measures G * 0 and G * 1 , using fixed hyperparameters m, m 1 , τ 2 , τ 2 1 , α σ , β σ , α τ , β τ , α 1 , and β 1 . We assume a uniform prior p 0 ∼ Unif(0.05, 1), conjugate normal priors on hyperparameters
2 ), and b 1 ∼ N(m 1 , τ 2 1 ), and inverse gamma priors on the variance parameters, σ 2 ∼ IG(α σ , β σ ), τ 2 ∼ IG(α τ , β τ ), and τ 2 1 ∼ IG(α 1 , β 1 ). The total mass parameter M in the DP priors is fixed as M = 1.
POSTERIOR INFERENCE
Posterior inference in the proposed model is carried out using MCMC simulation (Tierney, 1994) . Implementation is greatly simplified by two computational devices. Firstly, as usual with DP models, posterior simulation is based on the the marginal posterior, after marginalizing with respect to the unknown random functions f 0 and f 1 . See, for example, MacEachern (1998) . In other words, we do not represent the actual random functions f 0 and f 1 . Later, in section 4.2 we discuss an algorithm that allows us to add inference on f 0 and f 1 in a straightforward manner. The second computational strategy that simplifies implementation is related to the mixtures appearing at various levels of the proposed model.
One mixture appears in equation (5) when we construct the DP mixture of normal models for f 0 and f 1 . A second mixture appears in the representation of the sampling distribution f for the mixed sample in equation (1). MCMC in mixture models usually proceeds by deconvoluting the mixtures via the introduction of latent variables (Diebolt and Robert, 1994; Robert, 1996) . We will follow the same strategy here. The resulting MCMC scheme is no more difficult than posterior simulation in standard MDP models with DP mixtures of normals, as described, e.g. in MacEachern (1998) . In fact, the only difference is that minor modifications are required in calculating the resampling probabilities for some of the indicators. We elucidate these details below.
Markov Chain Monte Carlo Simulation
Posterior simulation is implemented by a Gibbs sampling scheme, iterating over draws from the complete conditional posterior distributions (Tierney, 1994) . For the construction of the Gibbs sampler, it is convenient to consider an equivalent representation of the involved mixtures as hierarchical models. The mixtures in (1) and (5) are replaced by a hierarchical model
with latent indicators r i ∈ {0, 1} defined by
The latent variables µ i break the DP mixtures assumed for f 0 and f 1 . The latent indicators r i break the additional mixture implied in the definition of f as f
MCMC posterior simulation proceeds as usual in DP mixture models, with a slightly modified expression for the conditional posterior probabilities used to re-sample the latent µ i . The key observation when considering the complete conditional posterior for µ i is that the latent µ i corresponding to the non-affected sample points z i , i = 1, · · · , n, can only have ties with other µ j 's that either correspond to other non-affected sample points, j ∈ {1, . . . , n}, or are imputed as arising from f 0 , i.e., j ∈ {n+1, . . . , 2n} and r j = 0. However, µ i , i = n+1, · · · , 2n, corresponding to sample points arising from the mixture can be matched with any other Here c is the common proportionality constant to ensure that the probabilities add up to one.
Let n − 0 = #{h : h = i and r h = 0} denote the number of data points different from z i with r indicator equal 0, and analogously for n − 1 . For i = n + 1, · · · , 2n, we jointly update µ i and r i with 
Inference on f 0 and f 1
The MCMC outlined in section 4.1 was greatly simplified by marginalizing with respect to the unknown distributions f 0 and f 1 . However, the final goal of our analysis is inference about P 1 = (1 − p 0 ) f 1 /f . Posterior inference on P 1 requires discussion of the posterior on f 0 and f 1 . In general, inference on the unknown distribution in DP mixture models is challenging. See Gelfand and Kottas (2002) for a discussion. However, some important simplifications are possible. Let Y denote the observed data. The posterior means, E(f 0 |Y ) and E(f 1 |Y ), can be shown to be equivalent to the posterior predictive distribution in the MDP model. We exploit this to evaluate posterior estimates for f 0 and f 1 . Using full conditional posterior distributions that are already evaluated in the course of the MCMC simulation we can further simplify the computation by using an ergodic average of these conditional predictive distributions. This allows computationally efficient evaluation of E(f 0 |Y ) and E(f 1 |Y ).
However, for the desired full posterior inference about the probability of differential expression P 1 more information is required. We need posterior samples from the posterior p(f j |Y ), j = 0, 1, on the unknown densities themselves. This is difficult in general. Below we describe a computational algorithm that allows easy (approximate) simulation in the context of the proposed model. First, using f 0 as example, we note that the posterior mean E(f 0 |Y ) is equal to the posterior predictive distribution. Let z 2n+1 denote a new Z null score. We find
Let θ denote the vector of all model parameters, and let θ (i) denote the parameters imputed after i iterations of the MCMC simulation. We evaluate p(z 2n+1 | Y ) as
The terms in the last average are easily computed. Recall that {µ * j , j = 1, . . . , k} are the unique values of the latent variables µ i , and r * j are the corresponding indicators r i . Without loss of generality assume that the µ * j are arranged with r * j = 0 for j = 1, . . . , k 0 and r * j = 1 for j = k 0 + 1, . . . , k. Let n j = #{i : µ i = µ * j } denote the number of µ i equal to µ * j and let N 0 = #{i : r i = 0} denote the number of r i = 0. We use a superindex (i) to identify the imputed parameter values after i iterations of the MCMC simulation. We find
Uncertainty in f 0 is illustrated through posterior draws of f 0 . For the following argument we consider augmenting the imputed parameter vector θ (i) with the random distribution G 0 defined in (5). Given θ (i) the conditional posterior for G 0 is a DP with updated parameters,
The large total mass parameter M + N (i) 0 implies that the random measure G 0 is close to the conditional expectation H 0 , the DP base measure in (10). We exploit this to approximate
and thus a posterior draw for f 0 as
The latter is simply the predictive distribution conditional on θ (i) in (9). The same mechanism can be applied to obtain samples from f 1 (z 2n+1 |Y ).
SIMULATION STUDY AND APPLICATION
In section 5.1, we perform a small simulation study to illustrate the proposed approach.
Results are compared with the known true parameter values in the simulation. In section 5.2, we analyze a colon data set from Alon (1999) , and compare the results under the proposed nonparametric Bayesian model with inference obtained from the empirical Bayes approach.
Simulation Study
We simulate a sample of n = 400 gene expression scores Z Bayesian nonparametric inference is set up according to the proposed approach. We fixed the hyperparameters as m = 0, m 1 = 1, α σ = 2, β σ = 1, α τ = 1, β τ = 0.2, α 1 = 1, and β 1 = 0.2. We summarize results here. We will use Y to generically denote the observed data. Figure 1 shows the posterior mean curves E(f 0 |Y ), E(f 1 |Y ) and E(f |Y ), together with the true distributions used in the simulation. Posterior inference correctly recovers the true curves. Not surprisingly, the bias for f 1 is larger than for f 0 and f . While f 0 and f are easily estimated by the relatively large samples, the data gives only indirect evidence for f 1 , implied by the deconvolution of (1). Figure 2 illustrates the uncertainty about the estimated Figure 1: Posterior mean curves E(f 0 |Y ), E(f 1 |Y ) and E(f |Y ) (solid curves) and true distributions (dashed curves). The higher bias in estimating f 1 reflects that the data includes only indirect information about f 1 . Inference has to be derived by deconvoluting the mixture
distributions.
Let P 1 (z i ) denote the marginal posterior probability E{P 1 (z i |f 0 , f 1 , p 0 )|Y } for every gene, i = 1, . . . , n. The structure of the proposed model implies that this marginal posterior probability of differential expression depends on the gene only through the observed score z i , making it meaningful to consider P 1 (z) as a function of z, as shown in Figure 3 . For reports marginal posterior probabilities of differential expression P 1 (z) across the three experiments (rows) and across z scores (columns). Posterior probabilities corresponding to rejection are highlighted in bold face. The rejection region is defined by a bound on the false discovery rate, FDR ≤ α (see the text for details). The first column reports the true value p 0 used in the simulations. Note how posterior inference automatically adjusts for the higher level of noise in the experiments with larger p 0 .
Observed z scores p 0 -5.00 -4.00 -3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 4.00 5.00 Figure 4 shows the uncertainty in P 1 .
The estimated posterior probabilities of differential expression can be used to carry out the multiple comparison to classify genes into affected and unaffected by the condition of interest. If we assume an underlying (0, 1, c) hypothesis testing loss we would declare all genes with P 1 (z i ) > c/(1 + c) as differentially expressed. Table 1 , second row, reports the marginal posterior probabilities P 1 (z) over a range of z values. In this example, using P 1 > 0.5 (i.e., c = 1) leads to classifying genes with |z| > 2.2 as differentially expressed.
The marginal posterior probabilities appropriately adjust for the observed level of noise. We illustrate this by considering two additional simulations with lower and higher proportions of non-differentially expressed genes, using (true) p 0 = 0.4 and with p 0 = 0.95, respectively.
For p 0 = 0.4 the cutoff shifts to |z| > 1.2. For higher levels of noise, p 0 = 0.95, the cutoff shifts even further to |z| > 5.2 (see Table 1 ). Alternatively, the shifting cutoff can be thought of as a Bayesian adjustment for multiplicities. With higher p 0 there is an increasingly larger number of false comparisons. Posterior probabilities appropriately adjust.
A useful generalization of frequentist type-I error rates to multiple hypothesis testing is the false discovery rate (FDR) introduced in Benjamini and Hochberg (2002) . Let δ i denote an indicator for rejecting the i-th comparison, i.e., flagging gene i as differentially expressed.
Recall from equation (8) FDR to microarray analysis are discussed by Storey and Tibshirani (2003) . Extensions are discussed by Genovese and Wasserman (2002, 2003) , who also introduce the definition of
We consider decision rules that classify a gene as differentially expressed if P 1 (z i ) > γ * . In analogy to classical hypothesis testing, we fix γ * as the minimum value that achieves a certain pre-set false discovery rate, FDR ≤ α. It can be shown (Müller et al., 2002) that under several loss functions that combine false negative and false discovery counts and/or rates the optimal decision rule is of this form. Figure 5 shows how the cutoff is obtained for three simulations with true p 0 = 0.4, 0.8 and 0.95. We use α = 0.45 (Since max P 1 (z i ) = 0.6 for the third simulation, it is impossible to achieve any FDR ≤ 0.4). Genes with FDR beyond the cutoff are highlighted in bold face in Table 1 . As before, the rule adjusts to increasing levels of noise by defining increasingly more conservative cutoffs.
Gene Expression Profiling of Colon Cancer
We analyze the data set reported in Alon et al. (1999) . The data format was described in Section 2. We compare inference under the proposed nonparametric Bayesian model with the empirical Bayes estimate (EMBA) discussed earlier.
The EMBA estimates posterior probabilities of differential expression P 1 (z|f 0 , f 1 , p 0 ) by substituting point estimates for f 0 /f and p 0 . The estimate for p 0 is derived as a bound on possible values for p 0 . In this data set we find p 0 = 0.39. In contrast, Figure 6 shows the marginal posterior distribution p(p 0 |Y ). The bound p 0 is far out in the tail of the posterior distribution, indicating that p 0 might lead to very conservative estimates for P 0 and P 1 (by underestimating P 1 ). Figures 7 through 9 show comparative inference for f 1 , f 0 , f and P 1 . As expected, the posterior mean curve P 1 (z) is estimated lower under the EMBA than under the proposed nonparametric Bayesian approach. Figure 8 summarizes the posterior However, often in practice, statistical significance does not necessarily imply strong biological significance. Thus, investigators may wish to calibrate between a desired FDR and the number of significant genes, as discussed in Section 5.1. For fixed values of α ranging from 0.001 to 0.2, threshold values on the observed scores z i , denoted as Z * , and the smallest cutoff γ * to achieve FDR ≤ α are depicted in Table 2 , along with the estimated number of significant genes. As |Z * | increases, the number of genes identified as significant by NPBA decreases along with a decreasing FDR. Investigators can use Table 2 to calibrate the results for the observed z-scores; γ * denotes the smallest cutoff to achieve FDR ≤ α. We also addressed the multiple testing issues that arise when dealing with a large number of simultaneous tests (genes). Using an appropriate definition of posterior expected false discovery rate, a close connection can be established with the final estimates of the posterior probabilities that automatically adjust for the proportion of noisy data, or equivalently, the true number of differentially expressing genes. A strength of the approach we have presented is that the rejection regions can be adaptively chosen to accommodate a pre-specified and biologically meaningful FDR chosen by the investigator; thus an appropriate threshold value can be directly calculated for the summary expression score to declare significance.
|Z
A critical assumption is that gene expression scores are independently identically distributed where the important aspect of the variation of gene expression across tissue samples can be captured sufficiently well by a binary variable (affected versus unaffected). While it is obvious that complex interactions between expression levels of several genes are likely to be present in practice (for example, as a result of carcinogenic pathways for cancer data), the underlying independence approximation is still useful to determine whether expression level differences are significant solely on a gene-by-gene basis. The approach described here can be extended to the exploration of gene interactions. Consider the simple subset of just two interacting genes. A natural extension of our approach is to choose a mixture of an appropriate bivariate distribution for the dual non-differentially expressed components, and several other mutually exclusive bivariate distributions for the differentially expressed components.
Our modeling framework allows for other kinds of elaboration including the combination of information across microarray technologies and gene-specific sensitivities (that may induce non-linearities in expression levels) due to different RNA preparations, different dyes, and different growth conditions. Further research into alternative prior structures to capture different sources of variation and potential interactions between genes will provide more precise estimates of differential gene expression and more accurate assessments of significant changes, thus reducing errors in downstream tasks, such as classification and cluster analysis.
Supplementary information and software updates are available at http://odin.mdacc.tmc.edu/~kim
